X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (321) 321
female (238) 238
oncology (222) 222
middle aged (194) 194
aged (183) 183
index medicus (180) 180
male (153) 153
adult (147) 147
cancer (92) 92
aged, 80 and over (87) 87
chemotherapy (87) 87
breast cancer (78) 78
breast neoplasms - pathology (64) 64
prognosis (61) 61
treatment outcome (60) 60
antineoplastic combined chemotherapy protocols - therapeutic use (56) 56
metastasis (56) 56
breast neoplasms - drug therapy (52) 52
care and treatment (48) 48
tumors (48) 48
carcinoma (47) 47
research (47) 47
survival (47) 47
medicine & public health (42) 42
risk factors (40) 40
retrospective studies (38) 38
cell line, tumor (37) 37
diagnosis (37) 37
italy (36) 36
neoplasm staging (36) 36
analysis (35) 35
disease-free survival (35) 35
expression (32) 32
therapy (32) 32
colorectal cancer (31) 31
neoplasm metastasis (31) 31
cancer therapies (29) 29
case-control studies (29) 29
cell biology (29) 29
animals (28) 28
prospective studies (27) 27
breast neoplasms - metabolism (26) 26
health aspects (24) 24
hematology, oncology and palliative medicine (24) 24
mutation (24) 24
survival analysis (24) 24
antineoplastic agents - therapeutic use (23) 23
antineoplastic combined chemotherapy protocols - adverse effects (23) 23
cancer research (23) 23
apoptosis (22) 22
studies (22) 22
trial (22) 22
article (21) 21
development and progression (21) 21
doxorubicin (21) 21
medicine (21) 21
breast neoplasms - genetics (20) 20
fluorouracil (20) 20
italy - epidemiology (20) 20
mice (20) 20
bone neoplasms - secondary (19) 19
clinical trials (19) 19
drug therapy (19) 19
fluorouracil - administration & dosage (19) 19
genetic aspects (19) 19
immunohistochemistry (19) 19
medical prognosis (19) 19
neoplasms. tumors. oncology. including cancer and carcinogens (19) 19
survival rate (19) 19
time factors (19) 19
antineoplastic agents - pharmacology (18) 18
biochemistry & molecular biology (18) 18
cancer patients (18) 18
cells (18) 18
patients (18) 18
research article (18) 18
apoptosis - drug effects (17) 17
biomarkers, tumor - metabolism (17) 17
bone metastases (17) 17
medicine, research & experimental (17) 17
risk (17) 17
women (17) 17
biology (16) 16
breast neoplasms - mortality (16) 16
breast-cancer (16) 16
docetaxel (16) 16
drug administration schedule (16) 16
mortality (16) 16
pathology (16) 16
adolescent (15) 15
biomarkers (15) 15
chemotherapy, adjuvant (15) 15
colorectal neoplasms - genetics (15) 15
disease (15) 15
efficacy (15) 15
follow-up studies (15) 15
gene expression regulation, neoplastic (15) 15
lung cancer (15) 15
management (15) 15
multidisciplinary sciences (15) 15
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2012, Volume 30, Issue 12, pp. 1378 - 1383
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2010, Volume 107, Issue 49, pp. 21098 - 21103
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2006, Volume 24, Issue 26, pp. 4293 - 4300
Purpose This phase II study of sorafenib, an oral multikinase inhibitor that targets Raf kinase and receptor tyrosine kinases, assessed efficacy, toxicity,... 
BAY-43-9006 | HEPATITIS-C VIRUS | TUMOR PROGRESSION | ONCOLOGY | KINASE | DOXORUBICIN | GENE-EXPRESSION | RESISTANCE | COMBINATION CHEMOTHERAPY | RAF/MEK/ERK PATHWAY | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Predictive Value of Tests | Extracellular Signal-Regulated MAP Kinases - blood | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Pyridines - pharmacokinetics | Male | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Benzenesulfonates - administration & dosage | Protein Kinase Inhibitors - adverse effects | RNA, Neoplasm - blood | Benzenesulfonates - adverse effects | Liver Neoplasms - blood | Benzenesulfonates - pharmacokinetics | Pyridines - adverse effects | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Carcinoma, Hepatocellular - genetics | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Antineoplastic Agents - pharmacokinetics | Carcinoma, Hepatocellular - blood | Pyridines - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Pyridines - administration & dosage | Drug Administration Schedule | Liver Neoplasms - genetics | Liver Neoplasms - drug therapy | Treatment Outcome | Biomarkers, Tumor - blood | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging
Journal Article
Nature Cell Biology, ISSN 1465-7392, 11/2012, Volume 14, Issue 11, pp. 1212 - 1222
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2011, Volume 29, Issue 16, pp. 2144 - 2149
Purpose To evaluate the effect of different first-line chemotherapy durations in patients with metastatic breast cancer (MBC) on overall survival (OS) and... 
SURVIVAL | ONCOLOGY | BIAS | PERIOD | CARCINOMA | TRENDS | INDUCTION TREATMENT | Disease-Free Survival | Medical Oncology - methods | Breast Neoplasms - pathology | Humans | Survival Analysis | Breast Neoplasms - mortality | Female | Treatment Outcome | Antineoplastic Agents - therapeutic use | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 05/2017, Volume 23, Issue 9, pp. 2195 - 2202
Journal Article
JAMA, ISSN 0098-7484, 01/2011, Volume 305, Issue 1, pp. 59 - 67
Journal Article